Plunkett Research Online: Biotest AG

BIOTEST AG (BTESF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Biotest AG focuses on hematology and immunology products, and develops, manufactures and sells plasma proteins and biotherapeutics. Biotest manufactures products based on human blood plasma immunoglobulins, clotting factors and albumins pertaining to diseases of the immune and hematopoietic systems.....



Biotest AG
Ticker: BTESF
Exchange: GREY
Parent Company: Creat Group Corporation
Year Established:
Employees:
Fiscal Year Ends in

Phone: 49 61 03 801 0
Fax: 49 61 03 801 150
Address: Landsteinerstrasse 5
Dreieich, 63303 Germany

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription

Bernhard EhmerCEO
Michael RamrothCFO
See More
Biotest AG focuses on hematology and immunology products, and develops, manufactures and sells plasma proteins and biotherapeutics. Biotest manufactures products based on human blood plasma immunoglobulins, clotting factors and albumins pertaining to diseases of the immune and hematopoietic systems.....See More See More

Auditor: Ernst & Young GmbH Wirtschaftspruefungsgesellschaft
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Haemoctin SDH
Haemonine
Intratect
Cytotect CP
Hepatect CP
Varitect CP
Pentaglobin
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: